Skip to content
Back to WST

West Pharmaceutical Services Inc

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
8
Purchases
0
Sales
8
Purchase value
$0.00
Sale value
$6.57M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Annette F FavoriteSr. VP & Chief HR Officer
4Rule 10b5-1 plan disclosed
Filed Sep 15, 2026Period of report Sep 11, 20260000105770-26-000110
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 15, 2026
Common Stock2,524$365.00$921.26K21,817.8098Direct
SaleSep 14, 2026
Common Stock2,500$355.00$887.50K21,817.8098Direct
SaleSep 11, 2026
Common Stock2,500$345.00$862.50K21,817.8098Direct
Filing footnotes · 1
  1. F1This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.
Open on SEC EDGAR
Annette F FavoriteSr. VP & Chief HR Officer
4
Filed Sep 10, 2026Period of report Sep 8, 20260000105770-26-000108
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 8, 2026
Common StockF12,817$340.81$960.06K16,844.5548Direct
SaleSep 8, 2026
Common StockF12,818$340.81$960.40K16,844.5548Direct
SaleSep 8, 2026
Common StockF12,500$340.81$852.03K16,844.5548Direct
Filing footnotes · 3
  1. F1The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price.
  2. F2This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018.
  3. F3This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.
Open on SEC EDGAR
Annette F FavoriteSr. VP & Chief HR Officer
4
Filed Apr 29, 2026Period of report Apr 27, 20260000105770-26-000054
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 27, 2026
Common StockF12,817$305.2018$859.75K16,828.4906Direct
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price.
  2. F2This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018.
Open on SEC EDGAR
Chad WintersVP, Chief Accounting Officer
4
Filed Apr 29, 2026Period of report Apr 27, 20260000105770-26-000053
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 27, 2026
Common StockF1896$300.6688$269.40K1,522.81Direct
Filing footnotes · 2
  1. F1The price reported in column 4 is a weighted average price.
  2. F2This award granted on February 18, 2020 vested in four equal annual installments beginning on February 18, 2021.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.